| RNAC Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the RNAC shares outstanding history going back to 8/4/2023:
Also see: RNAC Market Cap History RNAC YTD Return |
As of 4/23/2026 Cartesian Therapeutics has 29.38 million RNAC shares outstanding. Investors often track the RNAC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RNAC share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 8/4/2023.

| RNAC Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the RNAC shares outstanding history going back to 8/4/2023:
Also see: RNAC Market Cap History RNAC YTD Return |
| RNAC Shares Outstanding History Chart | |||||||||||||||||||||||||||
RNAC Historical Shares Outstanding: +90.15% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||
| RNAC Stock Price Chart |
| About Cartesian Therapeutics Inc |
| Cartesian Therapeutics, Inc. is a clinical-stage company. Co. is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapies for autoimmune diseases. Its lead asset e, Descartes-08, is an autologous mRNA chimeric antigen receptor T-cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), that the Co. is developing for the treatment of autoimmune diseases. Descartes-08 is in Phase II clinical development. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. We show 12 historical shares outstanding datapoints in our coverage of RNAC's shares outstanding history. Understanding the changing numbers of RNAC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RNAC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RNAC by allowing them to research RNAC shares outstanding history as well as any other stock in our coverage universe. |
| RNAC Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| RNAC Share Performance |
| Shares Outstanding Peers |
| Cartesian Therapeutics (RNAC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RNAZ Shares Outstanding History RNTX Shares Outstanding History RNXT Shares Outstanding History RPHM Shares Outstanding History RPID Shares Outstanding History RPRX Shares Outstanding History RSLS Shares Outstanding History RTIX Shares Outstanding History RTRX Shares Outstanding History RTTR Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.